Adjuvant hepatic arterial infusion pump chemotherapy and resection versus resection alone in patients with low-risk resectable colorectal liver metastases – the multicenter randomized controlled PUMP trial

Perioperative Hepatic Arterial Infusion Pump Chemotherapy Is Associated With Longer Survival After Resection of Colorectal Liver Metastases: A Propensity Score Analysis

(2017) Bas Groot Koerkamp et al.   JOURNAL OF CLINICAL ONCOLOGY

Resection Margin and Survival in 2368 Patients Undergoing Hepatic Resection for Metastatic Colorectal Cancer

(2015) Eran Sadot et al.   ANNALS OF SURGERY

Phase II Trial of Hepatic Artery Infusional and Systemic Chemotherapy for Patients With Unresectable Hepatic Metastases From Colorectal Cancer

(2015) Michael I. DʼAngelica et al.   ANNALS OF SURGERY

The use of neo-adjuvant chemotherapy in patients with resectable colorectal liver metastases: Clinical risk score as possible discriminator

(2015) N. Ayez et al.   EJSO

Adjuvant therapy after resection of colorectal liver metastases: the predictive value of the MSKCC clinical risk score in the era of modern chemotherapy

(2014) Nuh N Rahbari et al.   BMC CANCER

Conversion to Complete Resection and/or Ablation Using Hepatic Artery Infusional Chemotherapy in Patients with Unresectable Liver Metastases from Colorectal Cancer: A Decade of Experience at a Single Institution

(2013) John B. Ammori et al.   ANNALS OF SURGICAL ONCOLOGY

Fatty liver disease as a predictor of local recurrence following resection of colorectal liver metastases

(2013) Z. Z. R. Hamady et al.   BRITISH JOURNAL OF SURGERY

Perioperative FOLFOX4 chemotherapy and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC 40983): long-term results of a randomised, controlled, phase 3 trial

(2013) Bernard Nordlinger et al.   LANCET ONCOLOGY

Predictive Factors for the Benefit of Perioperative FOLFOX for Resectable Liver Metastasis in Colorectal Cancer Patients (EORTC Intergroup Trial 40983)

(2012) Halfdan Sorbye et al.   ANNALS OF SURGERY

Role of intra-arterial hepatic chemotherapy in the treatment of colorectal cancer metastases

(2010) T. Peter Kingham et al.   JOURNAL OF SURGICAL ONCOLOGY

Regional Hepatic Chemotherapies in Treatment of Colorectal Cancer Metastases to the Liver

(2010) John B. Ammori et al.   SEMINARS IN ONCOLOGY

Regional chemotherapy for unresectable primary liver cancer: results of a phase II clinical trial and assessment of DCE-MRI as a biomarker of survival

(2009) W. R. Jarnagin et al.   ANNALS OF ONCOLOGY

Conversion to Resectability Using Hepatic Artery Infusion Plus Systemic Chemotherapy for the Treatment of Unresectable Liver Metastases From Colorectal Carcinoma

(2009) Nancy E. Kemeny et al.   JOURNAL OF CLINICAL ONCOLOGY

Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial

(2008) Bernard Nordlinger et al.   LANCET

Regional Chemotherapy: A Focus on Hepatic Artery Infusion for Colorectal Cancer Liver Metastases

(2008) Don S. Dizon et al.   Surgical Oncology Clinics of North America